Related references
Note: Only part of the references are listed.Preliminary mechanism on the methylation modification of Dkk-1 and Dkk-3 in hepatocellular carcinoma
Libo Liang et al.
TUMOR BIOLOGY (2015)
The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus
Agostino Gaudio et al.
DIABETES & VASCULAR DISEASE RESEARCH (2014)
Extrahepatic Complications of Nonalcoholic Fatty Liver Disease
Matthew J. Armstrong et al.
HEPATOLOGY (2014)
Effect of liver dysfunction on circulating sclerostin
Yumie Rhee et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2014)
The Relationships Between Serum Sclerostin, Bone Mineral Density, and Vascular Calcification in Rheumatoid Arthritis
J. Paccou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?
R. Sapir-Koren et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Relationship of Dickkopf1 (DKK1) with Cardiovascular Disease and Bone Metabolism in Caucasian Type 2 Diabetes Mellitus
Antonia Garcia-Martin et al.
PLOS ONE (2014)
Circulating Dickkopf-1 in Diabetes Mellitus: Association With Platelet Activation and Effects of Improved Metabolic Control and Low-Dose Aspirin
Stefano Lattanzio et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Serum Sclerostin in Alcoholics: A Pilot Study
E. Gonzalez-Reimers et al.
ALCOHOL AND ALCOHOLISM (2013)
Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity
K. -H. William Lau et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study
Stergios A. Polyzos et al.
BIOMARKERS (2013)
The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women
Geeta Hampson et al.
BONE (2013)
Involvement of WNT/β-catenin Signaling in the Treatment of Osteoporosis
Maurizio Rossini et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
Serum sclerostin levels in healthy men over 50 years of age
Harjit Pal Bhattoa et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2013)
Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin and Dickkopf-1 Levels of Naive Postmenopausal Women With Low Bone Mass: A Randomized, Head-to-Head Clinical Trial
Athanasios D. Anastasilakis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups
Mark M. Smits et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver
Giovanni Musso et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Dickkopf-1: as a diagnostic and prognostic serum marker for early hepatocellular carcinoma
Hao Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2013)
Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children
P. E. Pardee et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Review article: non-alcoholic fatty liver disease and osteoporosis - clinical and molecular crosstalk
Y. Yilmaz
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
High Circulating Sclerostin is Present in Patients with Thalassemia-associated Osteoporosis and Correlates with Bone Mineral Density
E. Voskaridou et al.
HORMONE AND METABOLIC RESEARCH (2012)
Association between Nonalcoholic Fatty Liver Disease (NAFLD) and Osteoporotic Fracture in Middle-Aged and Elderly Chinese
Mian Li et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Nonalcoholic Fatty Liver Disease Multimodal Treatment Options for a Pathogenetically Multiple-hit Disease
Stergios A. Polyzos et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women-the six-month effect of risedronate and teriparatide
S. A. Polyzos et al.
OSTEOPOROSIS INTERNATIONAL (2012)
The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease
Tugrul Purnak et al.
WIENER KLINISCHE WOCHENSCHRIFT (2012)
Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women
Seong-Su Moon et al.
ENDOCRINE (2012)
Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
Judith Ertle et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge
Athanasios D. Anastasilakis et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2011)
Insulin receptor expression in bone
D. M. Thomas et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Wnt signaling in development and disease
Jennifer L. Freese et al.
NEUROBIOLOGY OF DISEASE (2010)
Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines
Stergios A. Polyzos et al.
CURRENT MOLECULAR MEDICINE (2009)
The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective
Mariana Lazo et al.
SEMINARS IN LIVER DISEASE (2008)
Gone with the Wnts:: β-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism
Stavros C. Manolagas et al.
MOLECULAR ENDOCRINOLOGY (2007)
LRP6 mutation in a family with early coronary disease and metabolic risk factors
Arya Mani et al.
SCIENCE (2007)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Expression of parathyroid hormone-related peptide and insulin-like growth factor I during rat fracture healing
K Okazaki et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2003)
Share Paper
